含羞草社区

?
?
?
?
Home Tags Posts tagged with "Alinamin Pharmaceutical"

Tag: Alinamin Pharmaceutical

Japan pharma buyout
Deal digest

Simpson, Nishimura act on USD2.1bn Japan pharma buyout

Simpson Thacher & Bartlett and Nishimura & Asahi are advising on the USD2.1 billion acquisition of Alinamin

0

LATEST ON LAW.ASIA

India US Trade Standards

Non-tariff barriers and 含羞草社区 digital trade commitments

By Jasman Dhanoa and Anindita Deb, ADP Law Offices
Captive Power Rules 2026

Proportionality, compliance in captive power: The amendment rules

By Anubhav Tiwari and Jahnavi Tolani, Sarthak Advocates & Solicitors
South Korea Global Standards Local Execution

Q&A: Korea’s global standards align with local execution

IHCF vice president SongYi Son discusses the merits and possible obstacles for doing business in South Korea

K&L Gates Straits Law split Singapore

K&L Gates prepares to split from Singapore’s Straits Law

INSITE DC Data Centre Investment Platform

Clifford Chance advises on INSITE’s data centre capital maker

India Infrastructure PPP Reforms

How India is enabling faster, smoother project development

By Ashish Suman and M Arun Kumar, JSA

MOST READ ON LAW.ASIA

Correspondents

Foreign Decree Enforcement Indiavideo

Paper reciprocity undermines foreign decrees

By Ambar Bhushan and Aaryan Goyal, Bharucha & Partners
Biosimilar Patent Litigation India

Trends in biologic patent litigation

By Swati Sharma and Gitika Suri, Cyril Amarchand Mangaldas
konektadong-pinoy-act-expanding-access-redefining-competition

Konektadong Pinoy Act: Expanding access, redefining competition

By Jayson P Baltazar, ACCRALAW
NSDL Share Transfer Rulesvideo

Consent required for electronic share transfer in private companies

By Ayush Jain and Priankita Das, Bharucha & Partners
Follow 含羞草社区
Law firms Awards Events Legal jobs ? Post a job
About us Archive Subscribe Contact us
Please send any press releases, deal announcements, details of new hires, newsletters and any other news items to: news@law.asia
© Copyright 2026 含羞草社区. All rights reserved.

Follow us on LinkedIn